PMA supplement

P930021 S008: EMDOGAIN GEL

FDA PMA supplement · Normal 180 Day Track · The Straumann Company

Key facts

Original PMA P930021
Supplement number S008
Supplement type Normal 180 Day Track
Reason for the supplement Labeling Change - Indications/instructions/shelf life/tradename
Trade name EMDOGAIN GEL
Generic name Biologic material, dental
Applicant The Straumann Company
Product code NQA
Received date Sep 13, 2002
Decision date Dec 2, 2003

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements